Granite Point Capital Management, L.P. Voyager Therapeutics, Inc. Transaction History

Granite Point Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$2.63 - $4.12 $170,950 - $267,800	-65,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.94 - $5.44 $256,100 - $353,600	65,000 New	65,000 $268,000
Q1 2020 May 12, 2020	SELL	$6.8 - $14.66 $120,020 - $258,749	-17,650 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$12.82 - $16.85 $226,273 - $297,402	17,650 New	17,650 $246,000

128

36.7M

48K

36.2K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $272M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.